Selected article for: "antiviral effect and possible antiviral effect"
Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
  • Document date: 2020_4_14
    • ID: d7stppv5_51
    Snippet: We employed ordinary differential equation models to analyze the in-host SARS CoV-2 dynamics in infected individuals and the potential in vivo effect of different treatment strategies. First, we fit models to the viral load data from different sources using a nonlinear-mixed effects approach. Second, we used pharmacokinetics models to fits observed plasma concentration of remdesivir (RDV) and its active nucleoside triphosphate form in PBMCs, and .....
    Document: We employed ordinary differential equation models to analyze the in-host SARS CoV-2 dynamics in infected individuals and the potential in vivo effect of different treatment strategies. First, we fit models to the viral load data from different sources using a nonlinear-mixed effects approach. Second, we used pharmacokinetics models to fits observed plasma concentration of remdesivir (RDV) and its active nucleoside triphosphate form in PBMCs, and blood concentration of hydroxychloroquine (HCQ). Third, we simulated dose response curves for antiviral effect of RDV and HCQ using different possible half maximal effective concentration (EC50) based on in-vitro estimations against SARS-CoV-2. Fourth, we simulated therapy at different times during infection to analyze the potential reduction of SARS CoV-2 shedding. Finally, we repeated projections of therapy including the emergence of resistance to therapy.

    Search related documents:
    Co phrase search for related documents
    • infected individual and ordinary differential equation model: 1, 2
    • infected individual and response curve: 1
    • infected individual and SARS shedding: 1, 2
    • infected individual and treatment strategy: 1
    • infected individual and vivo effect: 1
    • model fit and nonlinear mixed effect: 1, 2
    • model fit and nonlinear mixed effect approach: 1
    • model fit and nucleoside PBMCs triphosphate form: 1
    • model fit and ordinary differential equation model: 1, 2, 3, 4, 5
    • model fit and PBMCs triphosphate form: 1
    • model fit and pharmacokinetic model: 1, 2, 3
    • model fit and plasma concentration: 1, 2, 3
    • model fit and response curve: 1, 2, 3
    • model fit and SARS shedding: 1
    • model fit and treatment strategy: 1, 2, 3, 4, 5
    • model fit and triphosphate form: 1
    • nonlinear mixed effect and pharmacokinetic model: 1, 2
    • nonlinear mixed effect and plasma concentration: 1
    • nucleoside PBMCs triphosphate form and PBMCs triphosphate form: 1, 2, 3